Galaxy Medicare Stock Price Today (NSE: GML)
Fundamental Score
Galaxy Medicare Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Galaxy Medicare share price today is ₹16.70, up +0.00% on NSE/BSE as of 3 August 2026. Galaxy Medicare (GML) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹27.46 (Cr). The 52-week high for GML share price is ₹23.80 and the 52-week low is ₹16.20. At a P/E ratio of 8.03x, GML is currently trading below its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 10.61% and a debt-to-equity ratio of 0.10.
Galaxy Medicare Share Price Chart — NSE/BSE Historical Performance
Galaxy Medicare share price chart: -8.47% return over the past month. 52-week high ₹23.80, 52-week low ₹16.20.
Galaxy Medicare — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹16.25 | ₹16.75 | ₹16.25 | ₹16.75 | 4.00K (Cr) | |
| ₹16.80 | ₹17.20 | ₹16.80 | ₹16.90 | 8.00K (Cr) | |
| ₹17.20 | ₹17.20 | ₹17.20 | ₹17.20 | 4.00K (Cr) | |
| ₹17.60 | ₹17.60 | ₹17.60 | ₹17.60 | 2.00K (Cr) | |
| ₹17.60 | ₹17.60 | ₹17.60 | ₹17.60 | 2.00K (Cr) | |
| ₹17.55 | ₹17.55 | ₹17.55 | ₹17.55 | 2.00K (Cr) | |
| ₹18.15 | ₹18.15 | ₹18.00 | ₹18.10 | 10.00K (Cr) | |
| ₹18.25 | ₹18.30 | ₹18.25 | ₹18.30 | 4.00K (Cr) | |
| ₹19.50 | ₹19.75 | ₹19.50 | ₹19.75 | 12.00K (Cr) | |
| ₹18.10 | ₹19.80 | ₹18.10 | ₹19.75 | 10.00K (Cr) |
Galaxy Medicare — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹18.25 | ₹18.30 | ₹16.25 | ₹16.75 | -8.22% | |
| ₹19.50 | ₹19.75 | ₹19.50 | ₹19.75 | +1.28% | |
| ₹20.25 | ₹20.25 | ₹18.10 | ₹19.75 | -2.47% | |
| ₹17.25 | ₹19.65 | ₹17.25 | ₹19.20 | +11.30% | |
| ₹16.90 | ₹18.05 | ₹16.20 | ₹17.30 | +2.37% | |
| ₹18.50 | ₹19.50 | ₹18.40 | ₹18.40 | -0.54% | |
| ₹20.85 | ₹22.40 | ₹17.60 | ₹17.90 | -14.15% | |
| ₹18.55 | ₹23.80 | ₹18.20 | ₹22.00 | +18.60% | |
| ₹22.00 | ₹22.90 | ₹19.75 | ₹19.75 | -10.23% |
AI Research Briefing
Powered by Gemini · 2026-08-01
A illiquid micro-cap medical consumable supplier trapped in declining top-line growth and zero institutional interest.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Board of Galaxy Medicare recommended a final dividend of ₹0.35 per equity share following a financial year closure showing total revenue of ₹40.00 crores and net income of ₹3.42 crores for FY26. Trading activity remains heavily constrained by microcap liquidity limits, with daily volumes hovering around 4,000 shares and total traded values dipping under a lakh. No major fresh institutional order announcements or strategic expansions have hit the exchange wires over the last month.
CORE STORY (THE REAL GAME)
A micro-cap contract supplier of basic surgical dressings and plaster bandages trying to survive in a commoditized medical consumables segment while wrestling with absolute lack of institutional sponsorship and zero free float velocity.
- Latest FY26 revenue printed at ₹40.00 crores with net income softening to ₹3.42 crores.
- Promoter holding steady at 72.98% with absolute zero FII and DII participation.
- Volume drying up with daily traded values slipping below ₹1 lakh.
- Sudden bulk institutional entry into the SME segment
- Massive government hospital supply contract wins exceeding ₹10 crores
- Aggressive capacity expansion or product pivot toward high-margin medical devices
- Severe micro-cap and SME liquidity risk with near-zero daily volume
- Contraction in latest quarterly YoY sales by 3.14% and profit by 15.66%
- Total absence of institutional sponsorship with DII exodus
Promoters hold 72.98% with a minor delta of 0.55%, while FII sits at 0.0% and DII completely exited with a 1.85% drop, leaving retail holding the bag.
India's broader medical device sector is expanding at an 8.30% CAGR toward USD 65.39 billion by 2034, but micro-caps like GML are completely detached from the structural tailwind.
No major institutional contract announcements or expansion orders found after live search.
yes — reported positive operating cash flow and free cash flow of ₹5.77 crores in FY25, though conversion has slowed down in FY26.
Continued range-bound stagnation and downward drift due to total absence of buying volume. Expect further valuation compression.
Primary Thesis Risk
Complete lack of market liquidity combined with shrinking quarterly top-line revenues.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Galaxy Medicare Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Galaxy Medicare Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GML across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 8.03 vs Industry: 36.70)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Profit Growth Track Record (35.10% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.10)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (17.82x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (72.98%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Profit Decline Concern (-15.66%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-3.63% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Galaxy Medicare vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Galaxy Medicare with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
39.5/100 | ₹16.70₹17 | ₹27.46₹27.46 | 8.03Average 8.0 Average | 10.61%Average 10.61% Average | 13.62%Average 13.62% Average | 0.10Excellent 0.1 Excellent | 35.10%Excellent 35.10% Excellent | 6.96%Good 6.96% Good | 1.93% | |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
Galaxy Medicare Quarterly Performance
Latest quarterly metrics for GML — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-3.14%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-15.66%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
6.96%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
35.10%
Compounded annual net profit growth over 5 years
Galaxy Medicare Technical Indicators
SMA 50, SMA 200, RSI and volume signals for GML — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Galaxy Medicare Financial Statements
Annual income statement, balance sheet and cash flow for Galaxy Medicare (GML) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Galaxy Medicare
About GML (Galaxy Medicare)
Galaxy Medicare (GML) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with ...a current market capitalisation of ₹27.46 (Cr). Galaxy Medicare has delivered a Return on Equity (ROE) of 10.61% and a ROCE of 13.62%. The debt-to-equity ratio stands at 0.10, reflecting the company's capital structure. Investors tracking GML share price can monitor key metrics including P/E ratio, promoter holding of 72.98%, and quarterly earnings growth.
Company Details
GML Share Price: Frequently Asked Questions
What is the current share price of Galaxy Medicare?
Galaxy Medicare (GML) trades at ₹16.70 on NSE. Market cap ₹27.46 (Cr). Educational data only.
What is the P/E ratio of Galaxy Medicare?
Galaxy Medicare has a P/E of 8.03x vs industry average 36.70x.
What is the Bull Run score for Galaxy Medicare?
Galaxy Medicare has a Bull Run score of 39.5/100 based on 25+ financial parameters.
Does Galaxy Medicare pay dividends?
Galaxy Medicare has a dividend yield of 1.93%. Past dividends don't guarantee future payments.
What is the ROE of Galaxy Medicare?
Galaxy Medicare has ROE of 10.61%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Galaxy Medicare?
Galaxy Medicare has debt-to-equity of 0.10.
Is Galaxy Medicare a good investment?
Bull Run gives Galaxy Medicare a score of 39.5/100. This is not investment advice — consult a SEBI-registered advisor.